Mairene Coto‐Llerena

1.9k citations
39 papers · 1.3k indexed · 2 hit papers · h-index 16
Topics
Hepatitis C virus research (15 papers)Hepatitis B Virus Studies (11 papers)Liver Disease Diagnosis and Treatment (7 papers)
Partner nations
SwitzerlandSpainItaly

In The Last Decade

Mairene Coto‐Llerena

38 papers receiving 1.3k citations

Hit Papers

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatoc...202120262022202420212023100200300

Peers

Mairene Coto‐Llerena
Comparison fields: 5 of 84
  • Molecular Biology 608
  • Cancer Research 436
  • Pulmonary and Respiratory Medicine 351
  • Hepatology 279
  • Oncology 243
Replace Karen Man‐Fong Sze with:
Karen Man‐Fong Sze Hong Kong
Yunlong Cui China
Arthur K. Ching Hong Kong
Johann von Felden Germany
Idrees Mian United States
Antonio Saviano France
Toshihiko Ohtomo Japan
Xiaoping Geng China
Joanna H.M. Tong Hong Kong
Mairene Coto‐Llerena relative to Karen Man‐Fong Sze Hong Kong Karen Man‐Fong Sze's profile →
Citations per field
00.5×3.1×
Karen Man‐Fong Sze · 1×
Citations per year

Countries citing papers authored by Mairene Coto‐Llerena

Since Specialization
Citations

This map shows the geographic impact of Mairene Coto‐Llerena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mairene Coto‐Llerena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mairene Coto‐Llerena more than expected).

Fields of papers citing papers by Mairene Coto‐Llerena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mairene Coto‐Llerena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mairene Coto‐Llerena. The network helps show where Mairene Coto‐Llerena may publish in the future.

Co-authorship network of co-authors of Mairene Coto‐Llerena

This figure shows the co-authorship network connecting the top 25 collaborators of Mairene Coto‐Llerena. A scholar is included among the top collaborators of Mairene Coto‐Llerena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mairene Coto‐Llerena. Mairene Coto‐Llerena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2
Arginine reprograms metabolism in liver cancer via RBM39breakdown →
145
3 15
4 88
5 16
6 14
7 17
8 6
9 13
10 7
11 10
12 12
13 50
14 6
15 75
16 21
17 5
18 4
19 63
20 13

About Mairene Coto‐Llerena

Mairene Coto‐Llerena is a scholar working on Hepatology, Cancer Research and Virology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Hepatology (279 citations), Cancer Research (436 citations) and Pulmonary and Respiratory Medicine (351 citations). Mairene Coto‐Llerena has collaborated with scholars based in Switzerland, Spain and Italy. Frequent co-authors include Salvatore Piscuoglio, Caner Ercan, Markus H. Heim, Ravi Kiran Reddy Kalathur, Gerhard Christofori, David Buechel, Fengyuan Tang, Ruize Gao, Michael T. Dill and Shuang Song. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026